Skip to content
2000
Volume 25, Issue 12
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

The global challenge of Multidrug-resistant Tuberculosis (MDR-TB) presents a substantial public health concern, requiring extended and complex treatment regimens. Understanding the factors impacting treatment results, particularly sputum culture conversion and Body Mass Index (BMI), is crucial. This retrospective cohort investigation conducted in Punjab, Pakistan, sought to explore the correlation between BMI and sputum culture conversion in individuals diagnosed with MDR-TB.

Material and Methodology

Data from 2663 confirmed MDR-TB patients across multiple Programmatic Management of Drug-Resistant Tuberculosis PMDT sites in Punjab, Pakistan, were retrospectively analyzed. Demographic and clinical characteristics, BMI, comorbidities, previous TB treatments, and drug resistance were evaluated. Cox proportional hazards regression models were employed to assess the association between time to sputum culture conversion and patient characteristics.

Results

The study compared MDR-TB treatment outcomes based on BMI categories (≥18.5 vs. <18.5 Kg/m^2). It involved 1626 employed patients, with a mean age of 33 ± 15 years, displaying baseline body weights averaging 48±7 kg (normal weight) and 37±6 kg (underweight). On average, sputum culture conversion occurred at four months, with approximately 37% achieving conversion within this period. Among several factors studied, the univariate analysis identified BMI <18.5 Kg/m^2, prior first-line drug treatment, and comorbidities as significantly associated with failure to achieve sputum culture conversion within 6 months. In multivariate analysis, the inability to achieve conversion was notably linked to BMI <18.5 Kg/m^2, previous first-line drug treatment, and resistance to fluoroquinolone drugs.

Conclusion

This study provided valuable insights into sputum culture conversion, BMI, and drug resistance among MDR-TB patients. While around half of the patients achieved sputum culture conversion within six months, factors, such as comorbidities, previous TB treatment, and drug resistance, significantly influenced treatment outcomes.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240342370241230194338
2025-01-17
2025-12-16

  • From This Site

    /content/journals/cmm/10.2174/0115665240342370241230194338
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmm/25/12/CMM-25-12-07.html?itemId=/content/journals/cmm/10.2174/0115665240342370241230194338&mimeType=html&fmt=ahah

References

  1. KaziG.N. EmanK. MohamudK.B. QuadirA. ShahS.K. HaqZ. Tuberculosis control in Pakistan: A decade (2011-2020) in review.Pak. J. Public Health2022121172210.32413/pjph.v12i1.955
     [Google Scholar]
  2. SotgiuG. SulisG. MatteelliA. Tuberculosis—a world health organization perspective.Microbiol. Spectr.201751211218
     [Google Scholar]
  3. AssemieM.A. AleneM. PetruckaP. LeshargieC.T. KetemaD.B. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis.Int. J. Infect. Dis.20209823023610.1016/j.ijid.2020.06.029 32535296
     [Google Scholar]
  4. KendallE.A. FofanaM.O. DowdyD.W. Burden of transmitted multidrug resistance in epidemics of tuberculosis: A transmission modelling analysis.Lancet Respir. Med.201531296397210.1016/S2213‑2600(15)00458‑0 26597127
     [Google Scholar]
  5. ParkH.O. KimS.H. MoonS.H. Association between body mass index and sputum culture conversion among South Korean patients with multidrug resistant tuberculosis in a tuberculosis referral hospital.Infect. Chemother.201648431732310.3947/ic.2016.48.4.317 27883374
     [Google Scholar]
  6. LeeY.J. HanS.K. ParkJ.H. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.Korean J. Intern. Med.201833593394010.3904/kjim.2017.249 29540054
     [Google Scholar]
  7. LuP. LiuQ. MartinezL. Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: A prospective cohort study from urban China.Eur. Respir. J.2017493160155810.1183/13993003.01558‑2016 28331033
     [Google Scholar]
  8. OrganizationW.H. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency update 2008.World Health Organization2008
     [Google Scholar]
  9. SongW. GuoJ. XuT. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.BMC Pulm. Med.202121139910.1186/s12890‑021‑01774‑2 34872558
     [Google Scholar]
  10. DobnerJ. KaserS. Body mass index and the risk of infection - From underweight to obesity.Clin. Microbiol. Infect.2018241242810.1016/j.cmi.2017.02.013 28232162
     [Google Scholar]
  11. PutriF.A. BurhanE. NawasA. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.Int. J. Tuberc. Lung Dis.201418556457010.5588/ijtld.13.0602 24903794
     [Google Scholar]
  12. ScrimshawN.S. Historical concepts of interactions, synergism and antagonism between nutrition and infection.J. Nutr.20031331316S321S10.1093/jn/133.1.316S 12514318
     [Google Scholar]
  13. PodewilsL.J. HoltzT. RiekstinaV. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients.Epidemiol. Infect.2011139111312010.1017/S0950268810000907 20429966
     [Google Scholar]
  14. KandaR. NagaoT. ThoN.V. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: A historical cohort study without censored cases.PLoS One20151011e014260710.1371/journal.pone.0142607 26558764
     [Google Scholar]
  15. IqbalZ. Ali KhanM. AzizA. NasirS.M. Time for culture conversion and its associated factors in multidrug-resistant tuberculosis patients at a tertiary level hospital in Peshawar, Pakistan.Pak. J. Med. Sci.20223844Part-II1009101510.12669/pjms.38.4.5058 35634598
     [Google Scholar]
  16. FrankM. AdamashviliN. LomtadzeN. KokhreidzeE. AvalianiZ. KempkerR.R. Long-term follow-up reveals high posttreatment mortality rate among patients with extensively drug-resistant tuberculosis in the country of Georgia Open Forum Infectious Diseases.Oxford University Press US2019
     [Google Scholar]
  17. AbubakarM. AhmadN. GhafoorA. Treatment outcomes of extensively drug-resistant tuberculosis in Pakistan: A countrywide retrospective record review.Front. Pharmacol.20211264055510.3389/fphar.2021.640555 33867989
     [Google Scholar]
  18. LiQ. LuM. HsiehE. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China.Medicine20209950e2364910.1097/MD.0000000000023649 33327347
     [Google Scholar]
  19. KhanI. AhmadN. KhanS. Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan.J. Infect. Public Health201912680981510.1016/j.jiph.2019.04.009 31056438
     [Google Scholar]
  20. SotgiuG. TiberiS. CentisR. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings.Int. J. Infect. Dis.20175619019310.1016/j.ijid.2016.10.021 27816662
     [Google Scholar]
  21. PalmeroD.J. AmbroggiM. BreaA. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.Int. J. Tuberc. Lung Dis.200486778784 15182150
     [Google Scholar]
  22. Sanchez-PadillaE. MarquerC. KalonS. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: A quantitative and qualitative study.Int. J. Tuberc. Lung Dis.201418216016710.5588/ijtld.13.0369 24429307
     [Google Scholar]
  23. MinionJ. GallantV. WolfeJ. JamiesonF. LongR. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: Demographic and disease characteristics.PLoS One201381e5346610.1371/journal.pone.0053466 23326436
     [Google Scholar]
  24. RobertJ. TrystramD. Truffot-PernotC. JarlierV. Multidrug-resistant tuberculosis: Eight years of surveillance in France.Eur. Respir. J.200322583383710.1183/09031936.03.00014103 14621093
     [Google Scholar]
  25. ChadhaS.S. BnS. ReddyK. Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.PLoS One2011611e2665910.1371/journal.pone.0026659 22073182
     [Google Scholar]
  26. MiglioriG.B. OrtmannJ. GirardiE. Extensively drug-resistant tuberculosis, Italy and Germany.Emerg. Infect. Dis.200713578078210.3201/eid1305.060200 18044040
     [Google Scholar]
  27. PrestinaciF. PezzottiP. PantostiA. Antimicrobial resistance: A global multifaceted phenomenon.Pathog. Glob. Health2015109730931810.1179/2047773215Y.0000000030 26343252
     [Google Scholar]
  28. RaviglioneM.C. GuptaR. DyeC.M. EspinalM.A. The burden of drug-resistant tuberculosis and mechanisms for its control.Ann. N. Y. Acad. Sci.2001953b1889710.1111/j.1749‑6632.2001.tb11364.x 11795426
     [Google Scholar]
  29. XieY.L. ChakravortyS. ArmstrongD.T. Evaluation of a rapid molecular drug-susceptibility test for tuberculosis.N. Engl. J. Med.2017377111043105410.1056/NEJMoa1614915 28902596
     [Google Scholar]
  30. JuréenP. WerngrenJ. ToroJ.C. HoffnerS. Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.Antimicrob. Agents Chemother.20085251852185410.1128/AAC.00110‑08 18316515
     [Google Scholar]
  31. JindalH.A. BhattB. MalikJ.S. A study on the smear conversion time and its associated factors in sputum positive category I tuberculosis DOTS cases in District Rohtak, Haryana.Sch J App Med Sci201539D33913399
     [Google Scholar]
  32. AsemahagnM.A. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: A longitudinal study.BMC Pulm. Med.202121111810.1186/s12890‑021‑01483‑w 33832466
     [Google Scholar]
  33. SinhaP. DavisJ. SaagL. Undernutrition and tuberculosis: Public health implications.J. Infect. Dis.201921991356136310.1093/infdis/jiy675 30476125
     [Google Scholar]
  34. BadeA.B. MegaT.A. NegeraG.Z. Malnutrition is associated with delayed sputum culture conversion among patients treated for MDR-TB.Infect. Drug Resist.2021141659166710.2147/IDR.S293461 33953577
     [Google Scholar]
  35. DuggalS ChughTD DuggalAK HIV and malnutrition: Effects on immune system.Clin Dev Immunol2012201210.1155/2012/784740
     [Google Scholar]
  36. BrownieS. Why are elderly individuals at risk of nutritional deficiency?Int. J. Nurs. Pract.200612211011810.1111/j.1440‑172X.2006.00557.x 16529597
     [Google Scholar]
  37. BaskaranN. LianL.S. JamludinN.A. Factors influencing delay in sputum conversion in smear-positive pulmonary tuberculosis patients in primary care in Kuala Lipis Pahang.Int. J. Health Sci.20226S74908492510.53730/ijhs.v6nS7.13077
     [Google Scholar]
  38. ZhangX. HanY. HuangW. JinM. GaoZ. The influence of the gut microbiota on the bioavailability of oral drugs.Acta Pharm. Sin. B20211171789181210.1016/j.apsb.2020.09.013 34386321
     [Google Scholar]
  39. Medellín-GaribayS.E. Cortez-EspinosaN. Milán-SegoviaR.C. Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: Association with biochemical and immunological parameters.Antimicrob. Agents Chemother.201559127707771410.1128/AAC.01067‑15 26438503
     [Google Scholar]
  40. FengJ.Y. HuangS.F. TingW.Y. Gender differences in treatment outcomes of tuberculosis patients in Taiwan: A prospective observational study.Clin. Microbiol. Infect.2012189E331E33710.1111/j.1469‑0691.2012.03931.x 22734962
     [Google Scholar]
  41. AbalA.T. JayakrishnanB. ParwerS. El ShamyA. AbahussainE. SharmaP.N. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis.Respir. Med.200599441542010.1016/j.rmed.2004.08.016 15763447
     [Google Scholar]
  42. MadzgharashviliT. SalindriA.D. MageeM.J. Treatment outcomes among pediatric patients with highly drug-resistant tuberculosis: The role of new and repurposed second-line tuberculosis drugs.J. Pediatric Infect. Dis. Soc.202110445746710.1093/jpids/piaa139 33347564
     [Google Scholar]
  43. AkçakirY. Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-TB): A systematic review and meta-analysis.McGill University2010
     [Google Scholar]
  44. TangS. TanS. YaoL. Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: Retrospective multi-center investigation.PLoS One2013812e8294310.1371/journal.pone.0082943 24349402
     [Google Scholar]
  45. MebrahtuT. Determinant Factors and Time To Sputum Smear And Culture Conversion Among Multidrug Resistant Tuberculosis Patients in St Peter’s Tuberculosis Specialized Hospital.Addis Ababa2011
     [Google Scholar]
  46. JohnstonJ.C. ShahidiN.C. SadatsafaviM. FitzgeraldJ.M. Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis.PLoS One200949e691410.1371/journal.pone.0006914 19742330
     [Google Scholar]
  47. OckengaJ. FuhseK. ChatterjeeS. Tuberculosis and malnutrition: The European perspective.Clin. Nutr.202342448649210.1016/j.clnu.2023.01.016 36857957
     [Google Scholar]
  48. OyewusiL. ZengC. SeungK.J. Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.Glob. Health Action2024171230593010.1080/16549716.2024.2305930 38305025
     [Google Scholar]
  49. LvL. LiT. XuK. Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis.Infect. Drug Resist.20181114715410.2147/IDR.S153499 29416359
     [Google Scholar]
  50. BecerraM.C. HuangC.C. LeccaL. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: Prospective cohort study.BMJ2019367l589410.1136/bmj.l5894 31649017
     [Google Scholar]
  51. KwanH.Y. MaddocksM. NolanC.M. The prognostic significance of weight loss in chronic obstructive pulmonary disease‐related cachexia: A prospective cohort study.J. Cachexia Sarcopenia Muscle20191061330133810.1002/jcsm.12463 31207189
     [Google Scholar]
/content/journals/cmm/10.2174/0115665240342370241230194338
Loading
Association between Sputum Culture Conversion and Body Mass Index among Multidrug-Resistant Tuberculosis Patients in Punjab, Pakistan: A Multicenter Retrospective Study
Current Molecular Medicine 25, 1525 (2025); https://doi.org/10.2174/0115665240342370241230194338
/content/journals/cmm/10.2174/0115665240342370241230194338
/content/journals/cmm/10.2174/0115665240342370241230194338
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): body mass index; fluoroquinolone drugs; multidrug-resistant; programmatic management of drugresistant tuberculosis; Sputum culture conversion; tuberculosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test